XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 41,134 $ 23,847
Adjustments to reconcile net income to cash flow from operating activities:    
Depreciation and amortization 163,112 163,066
Accretion of loan discounts and premiums, net (6,918) (8,239)
Amortization of deferred financing costs, net 2,070 2,534
Stock compensation expense 6,128 6,781
(Gain on sale) loss on impairment of real estate assets, net (11,066) 10,284
Gain on extinguishment of debt (203) 0
Amortization related to derivative instruments 907 973
Non-cash casualty losses 3,299 866
Equity in loss from investments in unconsolidated real estate entities 2,382 3,158
Other loss 1 1,261
Changes in assets and liabilities:    
Other assets (10,753) (9,276)
Accounts payable and accrued expenses 8,404 9,352
Accrued interest payable (1,059) 279
Other liabilities (1,119) (1,894)
Cash flow provided by operating activities 196,319 202,992
Cash flows from investing activities:    
Acquisition of real estate properties (81,220) 0
Cash, cash equivalents and restricted cash acquired in consolidation of unconsolidated joint venture 0 2,145
Investments in unconsolidated real estate entities (8,881) (23,221)
Return of investment in unconsolidated real estate entities 150 0
Proceeds from dispositions of real estate properties, net 390,817 35,557
Capital expenditures (92,057) (111,872)
Real estate development expenditures (41,894) (48,491)
Proceeds from insurance claims 4,028 3,265
Cash flow provided by (used in) investing activities 170,943 (142,617)
Cash flows from financing activities:    
Proceeds from unsecured credit facility and term loans 239,000 185,000
Unsecured credit facility, secured credit facility and term loan repayments (282,652) (127,513)
Mortgage principal repayments and payoffs (211,064) (6,067)
Costs associated with debt payoffs (663) 0
Payments for deferred financing costs (437) (60)
Distributions on common stock (108,064) (98,965)
Distributions to noncontrolling interests (2,852) (2,639)
Repurchase of shares related to equity award tax withholding (2,572) (4,739)
Costs from issuance of common stock, net (447) (421)
Cash flow used in financing activities (369,751) (55,404)
Net change in cash and cash equivalents, and restricted cash (2,489) 4,971
Cash and cash equivalents, and restricted cash, beginning of period 50,732 44,017
Cash and cash equivalents, and restricted cash, end of the period $ 48,243 $ 48,988